Lyra Therapeutics to Report Third Quarter 2021 Financial Results on November 9
WATERTOWN, Mass., Nov. 2, 2021 /PRNewswire/ — Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise, sustained, and local delivery of medications to the ear, nose and throat (ENT) passages and other…
Comments Off on Lyra Therapeutics to Report Third Quarter 2021 Financial Results on November 9